- Home
- ZBAI vs TNON Comparison
ZBAI vs TNON Comparison
Compare ZBAI & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBAI
- TNON
- Stock Information
- Founded
- ZBAI 2015
- TNON 2012
- Country
- ZBAI United States
- TNON United States
- Employees
- ZBAI N/A
- TNON N/A
- Industry
- ZBAI Professional Services
- TNON Medical Specialities
- Sector
- ZBAI Consumer Discretionary
- TNON Health Care
- Exchange
- ZBAI Nasdaq
- TNON Nasdaq
- Market Cap
- ZBAI 11.3M
- TNON 11.5M
- IPO Year
- ZBAI N/A
- TNON 2022
- Fundamental
- Price
- ZBAI $7.80
- TNON $1.12
- Analyst Decision
- ZBAI
- TNON Strong Buy
- Analyst Count
- ZBAI 0
- TNON 2
- Target Price
- ZBAI N/A
- TNON $5.50
- AVG Volume (30 Days)
- ZBAI 9.8K
- TNON 200.9K
- Earning Date
- ZBAI 12-18-2025
- TNON 11-13-2025
- Dividend Yield
- ZBAI N/A
- TNON N/A
- EPS Growth
- ZBAI N/A
- TNON N/A
- EPS
- ZBAI N/A
- TNON N/A
- Revenue
- ZBAI $720,000.00
- TNON $3,233,000.00
- Revenue This Year
- ZBAI N/A
- TNON $17.85
- Revenue Next Year
- ZBAI N/A
- TNON $85.60
- P/E Ratio
- ZBAI N/A
- TNON N/A
- Revenue Growth
- ZBAI 44.00
- TNON N/A
- 52 Week Low
- ZBAI $4.83
- TNON $0.85
- 52 Week High
- ZBAI $45.00
- TNON $5.85
- Technical
- Relative Strength Index (RSI)
- ZBAI 36.20
- TNON 42.03
- Support Level
- ZBAI $6.77
- TNON $1.11
- Resistance Level
- ZBAI $8.60
- TNON $1.23
- Average True Range (ATR)
- ZBAI 0.46
- TNON 0.05
- MACD
- ZBAI -0.18
- TNON -0.01
- Stochastic Oscillator
- ZBAI 7.00
- TNON 7.89
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.